Study Finds Avandia Does Not Lead to Heart Attacks
July 14, 2010
A study released at the American Diabetes Association Annual meeting finds the diabetes drug Avandia does not increase the risk for heart attack, contradicting recent reports.
Topics:
Health Medical Pharma, Diabetes, Health, Medicine, Thiazolidinediones, Rosiglitazone, Pyridines, American Diabetes Association, GlaxoSmithKline, Myocardial infarction, Aging-associated diseases, diabetes mellitus, Finds Avandia Does Not Lead to Heart Attacks A, the American Diabetes Association annual, Avandia, heart attack, Politics
